Biocognate Life Sciences Pvt. Ltd. was established with the sole vision of supporting biosimilars development and for the past two years has been engaged in the dissipation of technical knowhow in the domain. Biocognate extends its services in the form of developing and supplying high-quality recombinant biosimilar product cell lines along with easily scalable processes and analytical methodologies to its partners in the biopharma community who are interested in the clinical and commercial development of biosimilars. Unlike the standard CRO/CMO offerings, Biocognate plans to offer off-the-shelf, biosimilar product cell line and processes at the R&D scale. By offering a pipeline of ready-to-scale-up biosimilar cell lines with lab-scale processes, we ensure a significant reduction in the timeline of product development for our partners, thereby, radically increasing the speed to the clinic and accessibility of the product to patients.